You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

LS SCLC

Showing 51 - 75 of 522
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

SCLC,Extensive Stage Trial in Italy (Pembrolizumab/Olaparib)

Not yet recruiting
  • SCLC,Extensive Stage
  • Meldola, Forlì Cesena, Italy
  • +9 more
Nov 11, 2022

SCLC,Extensive Stage Trial in Hangzhou (Thoracic radiotherapy)

Recruiting
  • SCLC,Extensive Stage
  • Thoracic radiotherapy
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Sep 14, 2022

Small Cell Lung Cancer (SCLC), Follicular Lymphoma (FL), Castration Resistant Prostate Cancer (CRPC) Trial in Russian

Recruiting
  • Small Cell Lung Cancer (SCLC)
  • +2 more
  • Tucson, Arizona
  • +62 more
Jan 18, 2023

Long-standing Persistent AF Trial in New York (Farawave PFA catheter)

Not yet recruiting
  • Long-standing Persistent AF
  • Farawave PFA catheter
  • New York, New York
    Mount Sinai Hospital
Nov 7, 2023

Small Cell Lung Cancer Extensive Stage Trial in Jinan, Tianjin, Zhengzhou (IN10018, Tislelizumab, Carboplatin)

Not yet recruiting
  • Small Cell Lung Cancer Extensive Stage
  • Jinan, China
  • +2 more
Sep 10, 2023

Vasculopathy Trial (Atorvastatin 80 Mg Oral Tablet)

Not yet recruiting
  • Vasculopathy
  • Atorvastatin 80 Mg Oral Tablet
  • (no location specified)
Apr 6, 2022

TRAcking Non-small Cell Lung Cancer Evolution Through Therapy

Not yet recruiting
  • Lung Cancer, Non-small Cell
  • Small Cell Lung Cancer
    • (no location specified)
    Nov 16, 2022

    Small-cell Lung Cancer, Neuroendocrine Carcinoma Trial (Iadademstat, Paclitaxel)

    Not yet recruiting
    • Small-cell Lung Cancer
    • Neuroendocrine Carcinoma
    • (no location specified)
    Jun 13, 2022

    Lung Cancer, Lung Cancer Metastatic, Brain Metastases Trial in United States (Stereotactic Radiosurgery, Cerebrospinal fluid

    Recruiting
    • Lung Cancer
    • +5 more
    • Stereotactic Radiosurgery
    • Cerebrospinal fluid collection
    • Basking Ridge, New Jersey
    • +6 more
    Nov 11, 2022

    Extensive-stage Small-cell Lung Cancer, Liver Metastases Trial in Los Angeles, Ann Arbor (Bevacizumab)

    Not yet recruiting
    • Extensive-stage Small-cell Lung Cancer
    • Liver Metastases
    • Los Angeles, California
    • +2 more
    Oct 18, 2022

    Extensive-stage Small-cell Lung Cancer Trial in Pittsburgh (Durvalumab 50 MG/1 ML Intravenous Solution, Etoposide Injection,

    Not yet recruiting
    • Extensive-stage Small-cell Lung Cancer
    • Durvalumab 50 MG/1 ML Intravenous Solution
    • +4 more
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Oct 31, 2022

    SCLC, Extensive Stage Trial in Shanghai (AK112, Etoposide, Carboplatin)

    Recruiting
    • SCLC, Extensive Stage
    • Shanghai, Shanghai, China
      Shun Lu
    Oct 12, 2022

    Small Cell Lung Cancer Trial in Saint Louis (AL8326 low dose group, AL8326 middle dose group, AL8326 high dose group)

    Recruiting
    • Small Cell Lung Cancer
    • AL8326 low dose group
    • +2 more
    • Saint Louis, Missouri
      Siteman cancer center, Washington University
    Nov 1, 2022

    Advanced Solid Tumors Trial in United States (ABBV-706, Cisplatin, Budigalimab)

    Recruiting
    • Advanced Solid Tumors
    • Grand Rapids, Michigan
    • +3 more
    Dec 13, 2022

    Small Cell Lung Cancer Trial in Seoul (Durvalumab)

    Active, not recruiting
    • Small Cell Lung Cancer
    • Seongnam-si, Gyeonggi-do, Korea, Republic of
    • +1 more
    Nov 6, 2022

    Patients With Advanced Solid Tumor (Excluding NSCLC, SCLC, and Mesothelioma) With Results From a Multi-gene Next-generation

    Not yet recruiting
    • Patients With Advanced Solid Tumor (Excluding NSCLC, SCLC, and Mesothelioma) With Results From a Multi-gene Next-generation Sequencing (NGS) Panel (>30 Genes)
    • Minimal documentation
    • Extended documentation
    • Mannheim, Baden-Württemberg, Germany
    • +1 more
    Jan 18, 2023

    Extensive-stage Small-cell Lung Cancer Trial in China (serplulimab, Cisplatin, Carboplatin)

    Not yet recruiting
    • Extensive-stage Small-cell Lung Cancer
    • Shantou, Guangdong, China
    • +6 more
    Mar 1, 2023

    Small Cell Lung Carcinoma Trial in Italy (Atezolizumab, Carboplatin, Etoposide)

    Active, not recruiting
    • Small Cell Lung Carcinoma
    • Rionero In Vulture (PZ), Basilicata, Italy
    • +24 more
    Dec 12, 2022

    Extensive Stage Small Cell Lung Cancer Trial in France ([177Lu]Lu-DOTA-TATE, Tislelizumab, [68Ga]Ga-DOTA-TATE)

    Recruiting
    • Extensive Stage Small Cell Lung Cancer
    • Lille, France
    • +6 more
    Jan 23, 2023

    Small Cell Lung Cancer Limited Stage Trial in Germany (Durvalumab, standard of care)

    Recruiting
    • Small Cell Lung Cancer Limited Stage
    • Löwenstein, Baden-Würtemberg, Germany
    • +9 more
    May 18, 2022

    SCLC,Extensive Stage Trial in Omaha (RYZ101 Dose Level 1, RYZ101 Dose Level 2, RYZ101 Dose Level 3)

    Recruiting
    • SCLC,Extensive Stage
    • RYZ101 Dose Level 1
    • +6 more
    • Omaha, Nebraska
      Nebraska Cancer Specialists
    Nov 18, 2022

    Small Cell Lung Cancer Trial in Worldwide (BMS-986012 (anti-fucosyl-GM1), Nivolumab)

    Active, not recruiting
    • Small Cell Lung Cancer
    • BMS-986012 (anti-fucosyl-GM1)
    • Nivolumab
    • New York, New York
    • +15 more
    Sep 28, 2022

    Safety of Zepzelca in Adult Extensive Stage Small Cell Lung

    Recruiting
    • Extensive-stage Small-cell Lung Cancer
    • Huntsville, Alabama
    • +36 more
    Jul 25, 2022

    Small Cell Lung Cancer Trial in Cleveland (Alisertib)

    Not yet recruiting
    • Small Cell Lung Cancer
    • Cleveland, Ohio
      Cleveland Clinic
    Oct 18, 2023

    Small Cell Lung Cancer Extensive Stage Trial (quaratusugene ozeplasmid, atezolizumab)

    Not yet recruiting
    • Small Cell Lung Cancer Extensive Stage
    • quaratusugene ozeplasmid
    • atezolizumab
    • (no location specified)
    Jan 19, 2023